New FDA Drug Approvals for 2024 - Drugs.com
WEBThe following drugs have recently been approved by the FDA. Includes newly approved drugs and new indications for drugs already approved. See also: Generic approvals, Approval process, New indications & dosage forms
Novel Drug Approvals for 2023 | FDA - U.S. Food and Drug …
WEBSep 24, 2024 · FDA Novel Drug Therapy Approvals for 2023. In 2023, CDER approved 55 new drugs never before approved or marketed in the U.S., known as “novel” drugs.
Novel Drug Approvals for 2024 | FDA - U.S. Food and Drug …
WEBJul 29, 2024 · What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U.S. See Drugs@FDA for information about all of CDER’s approved drugs and biological products.
First new type of treatment for schizophrenia in decades - NPR
WEBSep 27, 2024 · A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to schizophrenia treatment. The Food and Drug Administration approved it Thursday.
FDA Approves Many New Drugs in 2023 that Will Benefit Patients …
WEBJan 9, 2024 · FDA’s Center for Drug Evaluation and Research (CDER) approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives.
FDA New Drug Approvals: The 16 Biggest Approvals of 2024 So …
WEBSep 3, 2024 · Wegovy (semaglutide), Tryvio (aprocitentan), and Ohtuvayre (ensifentrine) are three of the many innovative medications that gained new approvals in 2024. They’re all slated to make a big clinical impact for those who need them.
Here Are the New Drugs and Treatments We Could See in 2024
WEBJan 4, 2024 · 2023 was a strong year for innovative new drugs, with new medications for Alzheimer’s disease, weight loss, and the first treatment based on the gene-editing technology CRISPR.
FDA new drug approvals in Q2 2024 - Nature
WEBJul 15, 2024 · The approval attracting the biggest forecasts is ImmunityBio’s IL-15 receptor agonist Anktiva (nogapendekin alfa inbakicept), indicated in combination with the Bacillus...
New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 · The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
F.D.A. Approves a New Antipsychotic Drug - The New York Times
WEBSep 26, 2024 · The new drug arose, as so many do, out of a disappointment. Eli Lilly developed one of its ingredients, xanomeline, in the early 1990s as a treatment for dementia, but ultimately shelved it ...
- Some results have been removed